Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02415894 |
Recruitment Status :
Completed
First Posted : April 14, 2015
Last Update Posted : July 22, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Other Abortion |
Study Type : | Observational |
Actual Enrollment : | 172 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Ukraine |
Study Start Date : | April 2015 |
Actual Primary Completion Date : | April 2016 |
Actual Study Completion Date : | April 2016 |
- Rate of successful abortion [ Time Frame: 15 hours after start of misoprostol induction ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Having an ongoing pregnancy of 13-22 weeks gestation
- Be willing to undergo surgical completion if necessary
- Have no contraindications to study procedures, according to provider
- Be willing and able to consent to participate in the study
- Be willing to follow study procedures
Exclusion Criteria:
- Known allergy to mifepristone or misoprostol/prostaglandin
- Any contraindications to vaginal delivery, including placenta previa
- Unable to provide consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02415894
Ukraine | |
Odessa Regional Hospital | |
Odessa, Ukraine | |
Poltava City Maternity Hospital | |
Poltava, Ukraine | |
Vinnitsa Regional Hospital | |
Vinnitsa, Ukraine |
Study Director: | Tamar Tsereteli, MD, PhD | Gynuity Health Projects | |
Study Director: | Galina Maistruk, MD | Woman Health and Family Planning Charitable Foundation |
Responsible Party: | Gynuity Health Projects |
ClinicalTrials.gov Identifier: | NCT02415894 |
Other Study ID Numbers: |
1025 |
First Posted: | April 14, 2015 Key Record Dates |
Last Update Posted: | July 22, 2016 |
Last Verified: | July 2016 |